Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals.
Saved in:
| Title: | Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals. |
|---|---|
| Authors: | Liu, Yen‐Chun1,2 (AUTHOR), Jeng, Wen‐Juei1,2 (AUTHOR) rachel.jeng@gmail.com, Peng, Chien‐Wei1,2 (AUTHOR), Chien, Rong‐Nan1,2,3 (AUTHOR), Liaw, Yun‐Fan1,3 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Mar2024, Vol. 59 Issue 6, p762-773. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02692813 |
|---|---|
| DOI: | 10.1111/apt.17880 |
